AUTHOR=Han Ting-Rui , Yang Wen-Juan , Tan Qing-Hua , Bai Shuai , Zhong Huang , Tai Yang , Tong Huan 

TITLE=Gut microbiota therapy for nonalcoholic fatty liver disease: Evidence from randomized clinical trials

JOURNAL=Frontiers in Microbiology

VOLUME=13

YEAR=2023

URL=https://www.frontiersin.org/journals/microbiology/articles/10.3389/fmicb.2022.1004911

DOI=10.3389/fmicb.2022.1004911

ISSN=1664-302X

ABSTRACT=<p>Nonalcoholic fatty liver disease (NAFLD) has a high prevalence worldwide, but there are no medications approved for treatment. Gut microbiota would be a novel and promising therapeutic target based on the concept of the gut–liver axis in liver disease. We reviewed randomized controlled trials on gut microbiota therapy in NAFLD in this study to evaluate its efficacy and plausibility in NAFLD.</p>